Director dealings: Skyepharma CFO gets cash injection from Vectura merger
20th Jun 2016 13:41
(ShareCast News) - Skyepharma's chief financial officer Andrew Derodra has pocketed a healthy cash injection after the completion of the merger with Vectura. Derodra exercised nil-cost options over 150,000 Skyepharma shares that were a bonus in his long-term incentive plan that vested on completion
Read moreVectura reports strong rise in full-year earnings
26th May 2016 09:47
(ShareCast News) - Vectura´s full-year results edged past forecasts with analysts noting the sharp improvement in its free-cash-flow generation even as they pointed out several potential share price drivers which were looming increasingly closer on the horizon. The manufacturer of airways diseases t
Read moreVectura teams up with Propeller on inhaler plan
24th May 2016 09:30
(ShareCast News) - Vectura Group said it was joining forces with Propeller Health to develop inhalers that combine their two technologies. In a statement, Vectura said the plan was to use its dry powder inhaler technology with Propeller's FDA-cleared digital health platform to treat respiratory dise
Read moreDrug trials using Vectura's Fox nebuliser make progress
3rd May 2016 14:21
(ShareCast News) - A respiratory treatment being developed using Vectura's Fox nebuliser technology device has passed safety and efficacy trials and looks likely to be moved into a Phase II efficacy study in infants. Drug developer Ablynx has published positive results from first-in-infant Phase I/I
Read moreBroker tips: ARM, Tate & Lyle, Inchcape
1st Apr 2016 15:46
(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura. After another strong set of quarterly results, ARM remains the top pick as Numis
Read moreNumis adds Virgin Money, Derwent and Northgate to 'top picks' list
1st Apr 2016 15:34
(ShareCast News) - Numis sell-side analysts provided a list of their top picks among large and small cap stocks across the market, including ARM Holdings, Virgin Money, Derwent London, Tullow Oil, Northgate and Vectura. After another strong set of quarterly results, ARM remains the top pick as Numis
Read moreVectura receives support from Skyepharma shareholder
17th Mar 2016 11:52
(ShareCast News) - Vectura - which focuses on the development of pharmaceutical therapies for airways diseases - has received a letter of intent from a Skyepharma shareholder supporting the companies' proposed merger. Vectura said River and Mercantile Asset Management, which owns just under 4.8m Sky
Read moreSkyepharma and Vectura agree merger; Skyepharma swings to profit
16th Mar 2016 08:55
(ShareCast News) - Vectura and Skyepharma have reached an agreement on the terms of a recommended merger. Under the terms of the deal, Skyepharma shareholders will get 2.7977 new Vectura shares for each Skyepharma share. Based on Vectura's closing price of 146.60p on Tuesday, this values Skyepharma
Read moreWednesday broker round-up
10th Feb 2016 16:22
(ShareCast News) - Virgin Money: Nomura starts coverage at buy with a target of 445p. Domino's Pizza: Credit Suisse upgrades to outperform with a target price of 1100p. BBA Aviation: Goldman Sachs downgrades to neutral with 181p target. Greencore: Societe Generale reiterates hold with a 386p targe
Read moreMilestone payday for Vectura on new asthma therapy
10th Feb 2016 08:43
(ShareCast News) - Vectura Group's inhaler and formulation technology received a boost on Wednesday, with the completion of a significant milestone on the development of the VR315 product. The FTSE 250 company confirmed that the clinical study report had been finalised, triggering a cash milestone p
Read moreFTSE 250 movers: Zoopla helps keep market marginally in the black
8th Jan 2016 15:11
(ShareCast News) - The FTSE 250 remained in the black by mid-afternoon, but only just with the market up 0.27 points (0.00%) to 16,792.49. Zoopla Property Group surged nearly 7% after Berenberg issued an analysis of the media sector and reiterated its 'buy' rating for the property classifieds websit
Read moreVectura Group completes clinical trial, reveals US partner
8th Jan 2016 07:47
(ShareCast News) - Vectura Group made a big step forward in the development of two of its products on Friday, VR315 and VR506, with the completion of a US clinical trial and the disclosure of its US development partner. The FTSE 250 firm described VR315 as a generic, inhaled combination therapy of f
Read moreHigher royalties help lift Vectura interims
17th Nov 2015 07:39
(ShareCast News) - Pharmaceutical group Vectura has posted a 57% rise in interim earnings before interest, tax, depreciation and amortisation to £4.7m driven by a 35% jump in revenues to £26.1m. Vectura, which specialises in products to treat airways-related diseases, trimmed its pre-tax losses to £
Read moreVectura and Novartis win FDA approval for COPD combo
30th Oct 2015 08:09
(ShareCast News) - Vectura and giant Swiss partner Novartis have received US drug regulator approval for their combination treatment for patients with chronic obstructive pulmonary disease (COPD), triggering a sizeable milestone payment for the UK company. The FTSE 250 drug developer and project par
Read moreVectura gets cash payout as lung treatment partner reaches milestone
2nd Oct 2015 07:44
(ShareCast News) - Medical research firm Vectura said it is to receive a €5m (£3.6m) payment after its secret partner on a lung disease treatment achieved "an important development milestone in Europe". Vectura, which specialises in developing products for treating of airways-related diseases, said
Read more